Anti-XAF1 antibody
Specifications
| Product cat: | AB-06-4665 |
| Product type: | Primary antibody |
| Antigen: | XAF1 |
| Immunogen: | Amino acids 1-225 mapping at the N-terminus of XAF1 of human origin. |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:900-1:2400); Immunoprecipitation; Immunofluorescence |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (2G1) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | BIRC 4 binding protein antibody |
| BIRC4 binding protein antibody | |
| BIRC4-binding protein antibody | |
| BIRC4BP antibody | |
| HSXIAPAF 1 antibody | |
| HSXIAPAF1 antibody | |
| XAF 1 antibody | |
| XAF1 antibody | |
| XAF1_HUMAN antibody | |
| XIAP associated factor 1 antibody | |
| XIAP-associated factor 1 antibody | |
| XIAPAF1 antibody |
Target information
Seems to function as a negative regulator of members of the IAP (inhibitor of apoptosis protein) family. Inhibits anti-caspase activity of BIRC4. Induces cleavage and inactivation of BIRC4 independent of caspase activation. Mediates TNF-alpha-induced apoptosis and is involved in apoptosis in trophoblast cells. May inhibit BIRC4 indirectly by activating the mitochondrial apoptosis pathway. After translocation to mitochondria, promotes translocation of BAX to mitochondria and cytochrome c release from mitochondria. Seems to promote the redistribution of BIRC4 from the cytoplasm to the nucleus, probably independent of BIRC4 inactivation which seems to occur in the cytoplasm. The BIRC4-XAF1 complex mediates down-regulation of BIRC5/survivin; the process requires the E3 ligase activity of BIRC4. Seems to be involved in cellular sensitivity to the proapoptotic actions of TRAIL. May be a tumor suppressor by mediating apoptosis resistance of cancer cells.
Provider
Erpantech Laboratory
